NEWS & INSIGHTS

The patients

Exceptional cancer survivors are at the heart of our research. Meet the people whose journeys challenge what we know about cancer survival, and discover how their experiences, perspectives and voices are helping shape the future of cancer research.

Exceptional cancer survivors | Patient Committee | Advocates

Yann Bizien: 9 Years After a Stage IV Pancreatic Cancer Diagnosis

Aug 26, 2026

UntilAllSurvive.com: where cancer survivors share their inspiring stories

UntilAllSurvive.com: our brand new website featuring captivating exceptional cancer survivor journeys

Aug 4, 2026

Our Patient Committee is a key part of our scientific approach

We work closely with exceptional survivors, clinicians, researchers and patient advocates across our international network

Jun 16, 2026

until-all-survive-website-for-cancer-patients

UntilAllSurvive.com: we're launching a new website for cancer patients!

UntilAllSurvive.com: a new website for cancer patients!

Jul 2, 2026

What if improving cancer care started with listening more carefully to patients?

Patient perspective is the driving force behind our Rosalind Study

Jun 8, 2026

Advancing Cancer Research Through Patient Advocacy

Working hand in hand with patient advocates to advance Pancreatic Cancer Research

Mar 18, 2026

Yann-Bizien-early-onset-cancer-france-rising-rates-national-registry

Cure51's CEO Nicolas Wolikow and Yann Bizien: Under-50 Cancer cases are surging

Cure51's CEO Nicolas Wolikow and Yann Bizien addressing rising rates of early-onset Cancer in France

Jan 29, 2026

What is a Clinical Trial in Cancer Care? A Complete Guide for Patients

Jan 27, 2026

Chloé-Cure51-Exceptional-Cancer-Survivors-Database

"These Survivors Are So Rare": Cure51, The French Biotech Company Identifying Exceptional Survivors of Incurable Cancers

Despite pessimistic diagnoses, some patients live for many years, or are even cured. Cure51 studies these extraordinary cases to eradicate Cancer.

Dec 17, 2025

ROSALIND